HIV-1 envelope gp41 broadly neutralizing antibodies: hurdles for vaccine development.
HIV Envelope Protein gp41
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info